Pure Global AI
ANVISA registration 10322250137Valid until Jan 05, 2036

COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV

ANVISA Registration Number: 10322250137QIAGEN BIOTECNOLOGIA BRASIL LTDA.QIAGEN GMBHRisk Class IV
Device names
Technical name
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV
PT: PARÂMETROS COMBINADOS NO MESMO PRODUTO - CLASSE IV
Commercial name
QIAstat-Dx Meningitis/Encephalitis (ME) Panel
Risk class
Class IV
Registration details
Registration Number
10322250137
Process Number
25351184055202571
CNPJ
01334250000120
Company information
Manufacturer
QIAGEN GMBH
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Jan 05, 2026
Validity
05/01/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10322250137 and manufactured by QIAGEN GMBH. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until Jan 05, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.